Moderna Shares Went Up in Premarket Trading
More Covid-19 vaccines for the Omicron variant fears sent Moderna stock upward 2.8% in premarket trading.
More Covid-19 vaccines for the Omicron variant fears sent Moderna stock upward 2.8% in premarket trading.
Palo Alto Networks shares rose 2.8% in premarket trading after they beat Wall Street expectations for the third quarter and raised its revenue forecast for the year.